New TTSA Awards in Summer 2017 go to 4 Teams

New Phase I Awards funded July 2017

Kristalyn Gallagher, MD (Surgery) and Xian Chen (Biochemistry & Biophysics) are Co-PIs on a project titled Proteogenomic discovery of patient-specific, phenotypic markers for early diagnosis of invasive lobular carcinoma.

Timothy Gershon, MD (Neurology) and Kirk Wilhelmsen, MD (Genetics) are Co-PIs on a project titled Analyzing clonal diversity to improve risk stratification and therapy for meulloblastoma.

Phase I teams awarded a Phase II grant June 2017

Rich David, MD (Ophthalmology), Matthew Hirsch, PhD (Ophthalmology), and Brian Gilger, DVM, MS received continued funding for their project Prevention of Cornea Graft Rejection using AAV Gene Therapy.

Wesley Burks, MD (Pediatrics), Fernando Pardo-Manuel de Villena, PhD (Genetics), Michael Kulis, PhD (Pediatrics), and Martin Ferris, PhD (Genetics) received continued funding for their project Development and genetic characterization of a translational model of peanut allergy

If you would like further information about the TTSA awards click here.

2017 Emerging Challenges in Biomedical Research Grants

Three Teams receive the 2017 SOM funded ECBR grants.  This year's focus is Alzheimer's Disease.  The interdisciplinary teams use a diversity of techniques and approaches to Alzheimer's pathology and therapy.  The 2017 ECBR projects are:

Rich Meeker, PhD (Neurology) and Todd Cohen, PhD (Neurology) are Co-PIs leading a team of investigators on a project titled Inflammation, Aging and Alzheimer's Disease Vulnerability.  Other team members include Paul Carney, MD (Pediatric Neurology), Tom DeMarse, PhD (Neurology), Zibo Li, PhD (Radiology), Hong Yuan, PhD (Radiology) and Sheryl Moy, PhD (Psychiatry).

Mohanish Deshmuhk, PhD (Cell Biology & Physiology) and Todd Cohen, PhD (Neurology) are Co-PIs of the project titled Strategies from the Healthy Brain for Alzheimer's Disease: Focus on MiR-29.

Aravid Asokan, PhD (Genetics) and Juan Song, PhD (Pharmacology) are Co-PIs of the project titled Aquaporin gene therapy for Alzheimer's Disease.

For more information on the ECBR grants click here.  To read the announcement about the 2017 ECBR grants in Vital Signs click here.  

Welcome to the Office of Research

The Office of Research (OoR) seeks to support research at the School of Medicine.  This includes the infrastructure, communication and development necessary for a strong and growing research enterprise.  Collaboration is one of the great strengths of UNC-Chapel Hill's research enterprise and the SOM investigators, who have numerous projects and programs with investigators across campus.  Thus the OoR works closely with many different units and offices throughout the institution.  The Office is led by the SOM Vice Dean for Research, Dr. Blossom Damania.  For further information about the OoR team, please see People.  For information on the multiple committees with which the OoR interfaces, please see Communication, under About.  For the responsibilities and activities with which the OoR is engaged, please see Research. 

As part of the School of Medicine Strategic Plan, the OoR has partnered with TraCS to support  translational pilot projects engaging new translational research teams across the SOM.  The multi-phase Translational Team Science Awards (TTSA) were initiated in 2013 and have supported a diverse group of basic science and clinical teams.  Please go to the Research Funding section for more information on the TTSA grant process and TTSA research teams.  The next call for concepts will be in Fall 2016.  

In the Spring of 2016 the School initiated the Emerging Challenges in Biomedical Research (ECBR) as a new pilot project mechanism.  The intent of the new awards is to provide support for innovative, early stage research relevant to NIH priorities.  The supported projects are expected to lead to submission of novel interdisciplinary program project grants and multiple PI R01s by UNC SOM investigators.  The Spring 2016 challenge is to capture braod interdisciplinary expertise of SOM faculty relevant ot emergent insect-borne diseases.  It is anticipated that future funding challenges will be aligned with high profile research objectives such as concept clearances from NIH institutes and the Common Fund.  Awards will provide up to $60K for a 1 year period.  For further information and the Spring 2016 recipients go to the Research Funding section.

Office of Research Newsletter- March 2017